scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1047340328 |
P356 | DOI | 10.1007/S00210-004-0963-0 |
P698 | PubMed publication ID | 15365689 |
P50 | author | Odd Geiran | Q11993095 |
Erik Qvigstad | Q63762835 | ||
P2093 | author name string | Alberto J Kaumann | |
Finn Olav Levy | |||
Jan-Bjørn Osnes | |||
Peter Molenaar | |||
Tor Skomedal | |||
Trond Brattelid | |||
Halfdan Aass | |||
James A Lynham | |||
P2860 | cites work | Cloning, expression, and pharmacology of four human 5-hydroxytryptamine 4 receptor isoforms produced by alternative splicing in the carboxyl terminus | Q24319843 |
Isolation of the serotoninergic 5-HT4(e) receptor from human heart and comparative analysis of its pharmacological profile in C6-glial and CHO cell lines | Q24675224 | ||
Blockade of human atrial 5-HT4 receptors by GR 113808 | Q24685748 | ||
Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays | Q28140044 | ||
Expression of serotonin receptor mRNAs in blood vessels | Q28296354 | ||
The 5-HT4 receptor: molecular cloning and pharmacological characterization of two splice variants | Q28368220 | ||
Structure of the human serotonin 5-HT4 receptor gene and cloning of a novel 5-HT4 splice variant | Q28369138 | ||
5HT4(a) and 5-HT4(b) receptors have nearly identical pharmacology and are both expressed in human atrium and ventricle | Q32059490 | ||
Quantitative mRNA analysis of five C-terminal splice variants of the human 5-HT4 receptor in the central nervous system by TaqMan real time RT-PCR. | Q33951364 | ||
Cloning and characterization of a novel human 5-HT4 receptor variant that lacks the alternatively spliced carboxy terminal exon. RT-PCR distribution in human brain and periphery of multiple 5-HT4 receptor variants | Q34105746 | ||
5-HT4 receptors | Q34298897 | ||
Electrophysiological effects of 5‐hydroxytryptamine on isolated human atrial myocytes, and the influence of chronic β‐adrenoceptor blockade | Q35045973 | ||
Labelling with [125I]‐SB 207710 of a small 5‐HT4 receptor population in piglet right atrium: functional relevance | Q35872895 | ||
A 5-hydroxytryptamine receptor in human atrium | Q35888122 | ||
5-Hydroxytryptamine stimulates human isolated atrium but not ventricle | Q38566087 | ||
The Regulation of Contractile Activity in Muscle | Q39893178 | ||
Studies on the phosphorylation of the inhibitory subunit of troponin during modification of contraction in perfused rat heart | Q40037475 | ||
Do human atrial 5-HT4 receptors mediate arrhythmias? | Q40610626 | ||
Serotonin increases calcium current in human atrial myocytes via the newly described 5-hydroxytryptamine4 receptors | Q41082809 | ||
Phosphorylation of C-protein, troponin I and phospholamban in isolated rabbit hearts | Q41346387 | ||
Electrophysiological and antiarrhythmic effects of the atrial selective 5-HT(4) receptor antagonist RS-100302 in experimental atrial flutter and fibrillation | Q41701470 | ||
Cloning, pharmacological characterisation and tissue distribution of a novel 5-HT4 receptor splice variant, 5-HT4(i). | Q42460996 | ||
Use of a synthetic dodecapeptide (malantide) to measure the cyclic AMP-dependent protein kinase activity ratio in a variety of tissues | Q42794111 | ||
Piglet sinoatrial 5-HT receptors resemble human atrial 5-HT4-like receptors | Q43570922 | ||
Positive inotropic response to 5-HT in human atrial but not in ventricular heart muscle | Q43771222 | ||
Relationship between myocardial remodeling and neurohumoral activation in patients with cardiac failure | Q43771848 | ||
A 5-HT4-like receptor in human right atrium. | Q53858263 | ||
L-type calcium channel activity in human atrial myocytes as influenced by 5-HT. | Q54042506 | ||
Effect of 5-HT4 receptor stimulation on the pacemaker current If in human isolated atrial myocytes | Q63321134 | ||
Serotonin metabolism in the normal and failing hamster heart | Q66940483 | ||
A 5-HT4-like receptor in human left atrium | Q67491258 | ||
5-Hydroxytryptamine increases contractile force in porcine right atrium but not in left ventricle | Q67971691 | ||
5-HT4 receptors, present in piglet atria and sensitive to SDZ 205-557, are absent in papillary muscle | Q67975615 | ||
Endocardium modulates myocardial inotropic response to 5-hydroxytryptamine | Q69413794 | ||
Comparison of the densities of 5-HT4 receptors, beta 1- and beta 2-adrenoceptors in human atrium: functional implications | Q71345794 | ||
Sensitization of Human Atrial 5-HT 4 Receptors by Chronic β-Blocker Treatment | Q71807715 | ||
Serotonergic mechanisms in heart failure | Q72590601 | ||
5-Hydroxytryptamine causes rate-dependent arrhythmias through 5-HT4 receptors in human atrium: facilitation by chronic beta-adrenoceptor blockade | Q72688184 | ||
Blockade of human atrial 5-HT4 receptors by SB 207710, a selective and high affinity 5-HT4 receptor antagonist | Q72688960 | ||
Comparison between alpha-1 adrenoceptor-mediated and beta adrenoceptor-mediated inotropic components elicited by norepinephrine in failing human ventricular muscle | Q73045813 | ||
Analysis of gene expression patterns in small amounts of human ventricular myocardium by a multiplex RNase protection assay | Q74310511 | ||
Activation of beta2-adrenergic receptors hastens relaxation and mediates phosphorylation of phospholamban, troponin I, and C-protein in ventricular myocardium from patients with terminal heart failure | Q77781940 | ||
P433 | issue | 3 | |
P921 | main subject | serotonin | Q167934 |
heart failure | Q181754 | ||
P304 | page(s) | 157-166 | |
P577 | publication date | 2004-09-07 | |
P1433 | published in | Naunyn-Schmiedeberg's Archives of Pharmacology | Q1468251 |
P1476 | title | Functional serotonin 5-HT4 receptors in porcine and human ventricular myocardium with increased 5-HT4 mRNA in heart failure | |
P478 | volume | 370 |
Q61819782 | (-)-Adrenaline elicits positive inotropic, lusitropic, and biochemical effects through β2-adrenoceptors in human atrial myocardium from nonfailing and failing hearts, consistent with Gs coupling but not with Gi coupling |
Q41139399 | 5-HT4-elicited positive inotropic response is mediated by cAMP and regulated by PDE3 in failing rat and human cardiac ventricles |
Q36514263 | 5-hydroxytryptamine in the cardiovascular system: focus on the serotonin transporter (SERT). |
Q35563508 | Agents increasing cyclic GMP amplify 5-HT4-elicited positive inotropic response in failing rat cardiac ventricle |
Q54567679 | Altered expression of a limited number of genes contributes to cardiac decompensation during chronic ventricular tachypacing in dogs. |
Q45164756 | Altered platelet contents in survivors of early ischemic ventricular fibrillation: preliminary findings |
Q36704776 | Beta-adrenoceptor blocker treatment and the cardiac beta-adrenoceptor-G-protein(s)-adenylyl cyclase system in chronic heart failure |
Q46599816 | Cardiac PDEs and crosstalk between cAMP and cGMP signalling pathways in the regulation of contractility |
Q42966841 | Cardiac overexpression of the human 5-HT4 receptor in mice. |
Q36912182 | Cardiovascular responses produced by 5-hydroxytriptamine:a pharmacological update on the receptors/mechanisms involved and therapeutic implications. |
Q45945713 | Effect of piboserod, a 5-HT4 serotonin receptor antagonist, on left ventricular function in patients with symptomatic heart failure. |
Q42625973 | Effects of treatment with a 5-HT4 receptor antagonist in heart failure |
Q38738478 | Fading of 5-HT4 receptor-mediated inotropic responses to 5-hydroxytryptamine is caused by phosphodiesterase activity in porcine atrium |
Q85888495 | Human 5-HT₄receptor stimulation in atria of transgenic mice |
Q52654802 | Identification of serotonin 2A receptor as a novel HCV entry factor by a chemical biology strategy. |
Q39294424 | Non-conventional features of peripheral serotonin signalling - the gut and beyond |
Q37230983 | Ontogenic changes of the control by phosphodiesterase-3 and -4 of 5-HT responses in porcine heart and relevance to human atrial 5-HT(4) receptors. |
Q46252240 | Phosphorylation of phospholamban and troponin I through 5-HT4 receptors in the isolated human atrium |
Q37855541 | Platelets and cardiac arrhythmia |
Q35098633 | Porcine left atrial and sinoatrial 5-HT(4) receptor-induced responses: fading of the response and influence of development |
Q40398371 | Prucalopride is a partial agonist through human and porcine atrial 5-HT4 receptors: comparison with recombinant human 5-HT4 splice variants |
Q33544883 | Reference gene alternatives to Gapdh in rodent and human heart failure gene expression studies |
Q85910177 | Regulation of GAPDH expression by treatment with the β-adrenoceptor agonist isoprenaline--is GADPH a suitable loading control in immunoblot experiments? |
Q46950614 | Serotonin responsiveness through 5-HT2A and 5-HT4 receptors is differentially regulated in hypertrophic and failing rat cardiac ventricle |
Q86035071 | Surprises from a cardiac 5-HT₄TG mouse: spontaneous atrial arrhythmias by endogenous 5-HT of atrial origin? Different mechanism of arrhythmias through 5-HT₄ receptors and β-adrenoceptors? |
Q34166903 | Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders |
Q34429191 | The cardiac ventricular 5-HT4 receptor is functional in late foetal development and is reactivated in heart failure |
Q34993925 | The expanded biology of serotonin |
Q36835728 | beta3-adrenergic receptor activation increases human atrial tissue contractility and stimulates the L-type Ca2+ current |
Q55257365 | cAMP Catalyzing Phosphodiesterases Control Cholinergic Muscular Activity But Their Inhibition Does Not Enhance 5-HT4 Receptor-Mediated Facilitation of Cholinergic Contractions in the Murine Gastrointestinal Tract. |
Search more.